IVISION TECH SPA (IVN.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:IVN • IT0005554784

1.9 EUR
-0.48 (-20.17%)
Last: Feb 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, IVN scores 2 out of 10 in our fundamental rating. IVN was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of IVN have multiple concerns. While showing a medium growth rate, IVN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IVN has reported negative net income.
  • IVN had a positive operating cash flow in the past year.
IVN.MI Yearly Net Income VS EBIT VS OCF VS FCFIVN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • IVN has a worse Return On Assets (0.04%) than 65.08% of its industry peers.
  • IVN has a Return On Equity of 0.13%. This is in the lower half of the industry: IVN underperforms 65.08% of its industry peers.
  • The Return On Invested Capital of IVN (4.89%) is comparable to the rest of the industry.
  • IVN had an Average Return On Invested Capital over the past 3 years of 4.00%. This is significantly below the industry average of 9.98%.
  • The last Return On Invested Capital (4.89%) for IVN is above the 3 year average (4.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.04%
ROE 0.13%
ROIC 4.89%
ROA(3y)0.84%
ROA(5y)N/A
ROE(3y)3%
ROE(5y)N/A
ROIC(3y)4%
ROIC(5y)N/A
IVN.MI Yearly ROA, ROE, ROICIVN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 4 6

1.3 Margins

  • IVN has a Profit Margin of 0.08%. This is in the lower half of the industry: IVN underperforms 65.08% of its industry peers.
  • IVN's Operating Margin of 8.30% is in line compared to the rest of the industry. IVN outperforms 44.44% of its industry peers.
  • In the last couple of years the Operating Margin of IVN has declined.
  • IVN has a Gross Margin of 52.71%. This is in the lower half of the industry: IVN underperforms 60.32% of its industry peers.
  • In the last couple of years the Gross Margin of IVN has declined.
Industry RankSector Rank
OM 8.3%
PM (TTM) 0.08%
GM 52.71%
OM growth 3Y-34.07%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.35%
GM growth 5YN/A
IVN.MI Yearly Profit, Operating, Gross MarginsIVN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • IVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IVN has more shares outstanding
  • The debt/assets ratio for IVN has been reduced compared to a year ago.
IVN.MI Yearly Shares OutstandingIVN.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
IVN.MI Yearly Total Debt VS Total AssetsIVN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • IVN has an Altman-Z score of 1.18. This is a bad value and indicates that IVN is not financially healthy and even has some risk of bankruptcy.
  • IVN has a worse Altman-Z score (1.18) than 66.67% of its industry peers.
  • The Debt to FCF ratio of IVN is 8.94, which is on the high side as it means it would take IVN, 8.94 years of fcf income to pay off all of its debts.
  • IVN has a Debt to FCF ratio (8.94) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.64 indicates that IVN is somewhat dependend on debt financing.
  • IVN's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. IVN is outperformed by 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.94
Altman-Z 1.18
ROIC/WACC0.68
WACC7.18%
IVN.MI Yearly LT Debt VS Equity VS FCFIVN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that IVN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.31, IVN is doing worse than 63.49% of the companies in the same industry.
  • A Quick Ratio of 0.85 indicates that IVN may have some problems paying its short term obligations.
  • IVN's Quick ratio of 0.85 is on the low side compared to the rest of the industry. IVN is outperformed by 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.85
IVN.MI Yearly Current Assets VS Current LiabilitesIVN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.
  • IVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 68.42%.
  • Measured over the past years, IVN shows a very strong growth in Revenue. The Revenue has been growing by 87.46% on average per year.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3300%
Revenue 1Y (TTM)68.42%
Revenue growth 3Y87.46%
Revenue growth 5YN/A
Sales Q2Q%41.77%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVN.MI Yearly Revenue VS EstimatesIVN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
IVN.MI Price Earnings VS Forward Price EarningsIVN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IVN is valued cheaply inside the industry as 90.48% of the companies are valued more expensively.
  • IVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IVN is cheaper than 90.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.65
EV/EBITDA 5.93
IVN.MI Per share dataIVN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IVISION TECH SPA

BIT:IVN (2/4/2026, 7:00:00 PM)

1.9

-0.48 (-20.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.1%
Inst Owner ChangeN/A
Ins Owners65.71%
Ins Owner ChangeN/A
Market Cap15.03M
Revenue(TTM)17.61M
Net Income(TTM)13.30K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF 12.65
P/OCF 3.38
P/B 1.49
P/tB 2.91
EV/EBITDA 5.93
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY7.9%
OCF(TTM)0.56
OCFY29.63%
SpS2.23
BVpS1.27
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.13%
ROCE 6.76%
ROIC 4.89%
ROICexc 5.54%
ROICexgc 7.46%
OM 8.3%
PM (TTM) 0.08%
GM 52.71%
FCFM 6.75%
ROA(3y)0.84%
ROA(5y)N/A
ROE(3y)3%
ROE(5y)N/A
ROIC(3y)4%
ROIC(5y)N/A
ROICexc(3y)4.55%
ROICexc(5y)N/A
ROICexgc(3y)5.61%
ROICexgc(5y)N/A
ROCE(3y)5.53%
ROCE(5y)N/A
ROICexgc growth 3Y-9.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-13.26%
ROICexc growth 5YN/A
OM growth 3Y-34.07%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.35%
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.94
Debt/EBITDA 1.65
Cap/Depr 134.17%
Cap/Sales 18.54%
Interest Coverage 250
Cash Conversion 114.32%
Profit Quality 8932.33%
Current Ratio 1.31
Quick Ratio 0.85
Altman-Z 1.18
F-Score6
WACC7.18%
ROIC/WACC0.68
Cap/Depr(3y)136.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)68.42%
Revenue growth 3Y87.46%
Revenue growth 5YN/A
Sales Q2Q%41.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y151.87%
EBIT growth 3Y23.59%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y672.35%
OCF growth 3YN/A
OCF growth 5YN/A

IVISION TECH SPA / IVN.MI FAQ

What is the ChartMill fundamental rating of IVISION TECH SPA (IVN.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IVN.MI.


What is the valuation status for IVN stock?

ChartMill assigns a valuation rating of 2 / 10 to IVISION TECH SPA (IVN.MI). This can be considered as Overvalued.


How profitable is IVISION TECH SPA (IVN.MI) stock?

IVISION TECH SPA (IVN.MI) has a profitability rating of 1 / 10.